Last reviewed · How we verify
NCT07168837
Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction
NA trial testing Letrozole tablets in PCOS (Polycystic Ovary Syndrome) in 100 participants. Completed in 10 May 2024.
1 May 2024
Quick facts
| Lead sponsor | Al-Azhar University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 10 January 2023 |
| Primary completion | 1 May 2024 |
| Estimated completion | 10 May 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Letrozole tablets — full drug profile →
Conditions studied
- PCOS (Polycystic Ovary Syndrome) — all drugs for PCOS (Polycystic Ovary Syndrome) →
Sponsor
Al-Azhar University
Who can join
Adults 18 to 40, female only, with PCOS (Polycystic Ovary Syndrome). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Polycystic Ovarian Syndrome (PCOS) is the most common endocrine disorders in women of reproductive age. According to the World Health Organization (WHO) estimation revealed over 116 million women (3.4%) are affected by PCOS worldwide. Owing to the intricacy of this condition, various sets of diagnostic criteria have been initiated for the confirmation of PCOS which are: National Institute of Health, Rotterdam's Criteria, Androgen Excess and PCOS society. The prevalence of PCOS is estimated at about 4 to 21 % when it is diagnosed according to the Rotterdam criteria accounting for 75% of cases with anovulatory infertility.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07168837
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Letrozole tablets
Trials testing the same drug.
- NCT06861803 — Laboratory and Ultrasound Findings and Response to Letrozole in PCOS Patients · not yet recruiting
- NCT06354439 — Use of Letrozole for Ectopic Pregnancy · Phase 4 · recruiting
- NCT06367712 — Letrozole Alone Protocol Versus Using Letrozole and HCG Protocol · Phase 1 · completed
- NCT05601700 — Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial) · Phase 3 · recruiting
- NCT05198050 — Letrozole in Induction of Abortion of Anembryonic Pregnancy · NA · completed
Other recruiting trials for PCOS (Polycystic Ovary Syndrome)
Currently open trials in the same condition.
- NCT07197255 — Transcriptomic Profiling of Cumulus Cells From CAPA-IVM · recruiting
- NCT07159880 — Letrozole Extended vs Traditional Therapy for Ovulation Induction in Women With PCOS (PROLEx-PCOS) · NA · recruiting
- NCT07426146 — Feasibility Effects of a Low-GI, High-fibre Diet in PCOS: a Prospective Cohort Study in Remote Yunnan · recruiting
- NCT07448272 — Letrozole 5 mg for 10 Days Versus Letrozole 10 mg for 5 Days for Ovarian Stimulation in PCOS · NA · active not recruiting
- NCT06793085 — Pro- and Anti-inflammatory Cytokines in PCOS · recruiting
Other Al-Azhar University trials
Trials by the same sponsor.
- NCT06489327 — Comparing Two Doses of Oral Melatonin as Premedication in Children Undergoing Surgery · NA · recruiting
- NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
- NCT07500194 — Quad Helix vs RME for Posterior Cross-bite in Egyptian Children · NA · not yet recruiting
- NCT07360756 — Ultrasonographic ONSD as a Predictor of PDPH in Spinal Anesthesia for Cesarean Delivery · not yet recruiting
- NCT07343570 — Comparison of Quadratus Lumborum and Combined Groin Nerve Blocks for Postoperative Analgesia After Open Inguinal Hernia · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07168837 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Al-Azhar University
- Last refreshed: 11 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07168837.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing